Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

Condition:   Primary Biliary Cirrhosis Interventions:   Drug: Fuzhenghuayu;   Drug: UDCA Sponsor:   Xijing Hospital of Digestive Diseases Recruiting - verified September 2016

Source: ClinicalTrials.gov - January 28, 2016 Category: Research Source Type: clinical trials